Trial intelligence / Profile preview

Prevention of falls in older adults with calcium and vitamin D supplementation

2006-001643-63Phase 3Active

Sponsor
Gerencia de Atención Primaria
Start
May 2006
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of Calcium + cholecalciferol in bone fracture (Fx) and Sarcopenia, sponsored by Gerencia de Atención Primaria. Primary endpoints: Muscle function improvement, Muscle strength improvement and 2 more. Started May 2006; status: active.

02

Drugs

Calcium + cholecalciferol
03

Conditions

bone fracture (Fx)Sarcopenia

Beyond the preview

Go deeper on 2006-001643-63.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001643-63.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call